In this Letter, the statement: βThe authors declare competing financial interests: details accompany the full-text HTML version of the paper at www.nature.com/nature.β was missing from the Author Information section of the PDF and print versions of the manuscript; this has now been corrected.
Additional information
The online version of the original article can be found at 10.1038/nature12441
Rights and permissions
About this article
Cite this article
Hatzivassiliou, G., Haling, J., Chen, H. et al. Erratum: Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers. Nature 502, 258 (2013). https://doi.org/10.1038/nature12659
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature12659
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
